Neil Sheppard is an Immunologist educated in the UK at the Universities of Bristol and Oxford. He has over 18 years’ experience in the fields of vaccines and immunotherapies, including over a dozen years leading drug discovery and development programs in Big Pharma and Biotech.
The Sixth Annual BioHealth Capital Region Forum brought together industry leaders from across the region who discussed the accomplishments and strengths of the region as its member companies continue to innovate new therapies and medicines in one of the strongest bio-hub regions in the United States.
The state of Maryland is the global epicenter of vaccine research and development. This has never been more evident than right now as scores of Maryland companies have risen to the global challenge of developing the first approved vaccine for SARS-CoV-2.
Longhorn Vaccines & Diagnostics, which has offices in Bethesda, Maryland, and San Antonio, Texas, has been at the forefront of the battle against COVID-19. And now, the innovative company has released its latest product, PrimeStore Analyte Transport Media (ATM)Ⓡ, which could revolutionize antigen and molecular testing by completely eliminating the need for RNA and DNA extraction.
Maryland is the epicenter of biotech and life science innovation in the BioHealth Capital Region (BHCR). The state is home to a burgeoning life science ecosystem, including a rapidly growing cell and gene therapy industry, a robust and growing advanced biomanufacturing environment, and a deep network of leading research universities and critical government life science research entities.
Courtesy of Luke Daum, Chief Scientific Officer and Executive VP at Longhorn Vaccines and Diagnostics Good News – Featuring Johns Hopkins, Longhorn Vaccines and Diagnostics, and More… Across the country, [….]
Why does it take so long to develop vaccines? The current COVID-19 pandemic has raised questions about the logistics in creating a new vaccine. Some may be frustrated with the [….]
Breakthrough in Vaccine 2020 Conference Event Name: 3rd International Conference Vaccines & Vaccination (Vaccine 2020)| May 20-21, 2020 Theme: Advances in Immunology & Vaccine Technology and Their Impact Aim and [….]
Veteran Owned Diagnostics Supplier Tapped to Help alleviate COVID-19 Sample Collection Shortages April 28, 2020 Longhorn Vaccines & Diagnostics, located in Bethesda, Maryland, is a privately-held, veteran-run company that develops [….]
Six Johns Hopkins COVID-19 Programs that Reflect A Culture of Leadership from Clinical Research to Healthcare Innovation
